Abbott’s Cardiac Mapping System Cleared in Europe, Australia

November 4, 2020

Abbott has received CE mark certification and Australian approval for its EnSite X EP system, a 3D cardiac mapping platform.

The system maps the electrical signals that control cardiac rhythms, enabling physicians to identify electrical disruptions causing heart rhythm problems and to target ablation therapy.

The EnSite X EP system creates a 3D model of the patient’s heart anatomy and uses electromagnetic technology to accurately locate Abbott’s sensor-enabled catheters during treatment.

View today's stories